These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25931389)

  • 1. How tumour cell identity is established?
    Sánchez-García I
    Semin Cancer Biol; 2015 Jun; 32():1-2. PubMed ID: 25931389
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy.
    Vicente-Dueñas C; Hauer J; Ruiz-Roca L; Ingenhag D; Rodríguez-Meira A; Auer F; Borkhardt A; Sánchez-García I
    Semin Cancer Biol; 2015 Jun; 32():3-9. PubMed ID: 24530939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of mesenchymal stem cells by oncogenes.
    Eid JE; Garcia CB
    Semin Cancer Biol; 2015 Jun; 32():18-31. PubMed ID: 24938913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cell technology for dissecting the cancer epigenome.
    Semi K; Yamada Y
    Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular reprogramming in skin cancer.
    Song IY; Balmain A
    Semin Cancer Biol; 2015 Jun; 32():32-9. PubMed ID: 24721247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Making of Leukemia.
    González-Herrero I; Rodríguez-Hernández G; Luengas-Martínez A; Isidro-Hernández M; Jiménez R; García-Cenador MB; García-Criado FJ; Sánchez-García I; Vicente-Dueñas C
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Cellular Identity in Cancer.
    Roy N; Hebrok M
    Dev Cell; 2015 Dec; 35(6):674-84. PubMed ID: 26702828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early epigenetic cancer decisions.
    Martín-Lorenzo A; Gonzalez-Herrero I; Rodríguez-Hernández G; García-Ramírez I; Vicente-Dueñas C; Sánchez-García I
    Biol Chem; 2014 Nov; 395(11):1315-20. PubMed ID: 25205718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumoral reprogramming: Plasticity takes a walk on the wild side.
    Campos-Sánchez E; Cobaleda C
    Biochim Biophys Acta; 2015 Apr; 1849(4):436-47. PubMed ID: 25038581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells.
    Scaffidi P; Misteli T
    Cold Spring Harb Symp Quant Biol; 2010; 75():251-8. PubMed ID: 21047903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common themes of dedifferentiation in somatic cell reprogramming and cancer.
    Daley GQ
    Cold Spring Harb Symp Quant Biol; 2008; 73():171-4. PubMed ID: 19150965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming and Stemness.
    Laplane L
    Perspect Biol Med; 2015; 58(2):229-46. PubMed ID: 26750604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological cellular reprogramming and cancer.
    Abollo-Jiménez F; Jiménez R; Cobaleda C
    Semin Cancer Biol; 2010 Apr; 20(2):98-106. PubMed ID: 20188173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient oncogenes.
    Lenz G
    Med Hypotheses; 2010 Dec; 75(6):660-2. PubMed ID: 20800367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of iPS cell technology to cancer epigenome study: uncovering the mechanism of cell status conversion for drug resistance in tumor.
    Matsuda Y; Semi K; Yamada Y
    Pathol Int; 2014 Jul; 64(7):299-308. PubMed ID: 25047500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-based system in stem cell reprogramming; differentiation/dedifferentiation.
    Pourrajab F; Babaei Zarch M; BaghiYazdi M; Hekmatimoghaddam S; Zare-Khormizi MR
    Int J Biochem Cell Biol; 2014 Oct; 55():318-28. PubMed ID: 25150833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell reprogramming: blood, neurons, and beyond.
    Robin C; Jaffredo T; Zaehres H
    FEBS Lett; 2019 Dec; 593(23):3241-3243. PubMed ID: 31814136
    [No Abstract]   [Full Text] [Related]  

  • 18. Neural stem cells in health and disease.
    Schwartz PH
    Methods; 2018 Jan; 133():1-2. PubMed ID: 29425545
    [No Abstract]   [Full Text] [Related]  

  • 19. Concerns about targeting cancer stem cell for cancer therapy.
    Yang G; Lu X; Fu H; Jin L; Yao L; Lu Z
    Med Hypotheses; 2011 Mar; 76(3):457. PubMed ID: 21288650
    [No Abstract]   [Full Text] [Related]  

  • 20. Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture.
    Shimamoto A; Kagawa H; Zensho K; Sera Y; Kazuki Y; Osaki M; Oshimura M; Ishigaki Y; Hamasaki K; Kodama Y; Yuasa S; Fukuda K; Hirashima K; Seimiya H; Koyama H; Shimizu T; Takemoto M; Yokote K; Goto M; Tahara H
    PLoS One; 2014; 9(11):e112900. PubMed ID: 25390333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.